v3.25.2
LEASES (Tables) - Maius Pharmaceutical Co. Ltd [Member]
6 Months Ended 12 Months Ended
Mar. 31, 2025
Sep. 30, 2024
Restructuring Cost and Reserve [Line Items]    
SCHEDULE OF SUPPLEMENTAL BALANCE SHEET INFORMATION FOR LEASES

Supplemental balance sheet information for leases was as follows:

 

         
   March 31, September 30, 
  

2025

(unaudited)

   2024 
Operating lease:          
Operating lease ROU assets  $56,132   $75,687 
           
Current operating lease obligation  $39,736   $40,106 
Total operating lease obligation  $39,736   $40,106 

Supplemental balance sheet information for leases was as follows:

 

   2024   2023 
   As of September 30, 
   2024   2023 
Operating lease:          
ROU assets  $75,687   $27,023 
           
Current operating lease obligation  $40,106   $22,087 

SCHEDULE OF UNDISCOUNTED FUTURE MINIMUM LEASE PAYMENT  

The undiscounted future minimum lease payment schedule as of September 30, 2024 is as follows:

 

SCHEDULE OF UNDISCOUNTED FUTURE MINIMUM LEASE PAYMENT 

      
Within 1 year  $41,801 
2026   26,601 
Less: interest   2,019 
Present value of lease liabilities  $66,383